British American Tobacco (BAT) can be a hard sell, particularly to the increasing number of "woke" investors.

Globally — barring a handful of emerging markets — cigarette sales are steadily being stubbed out. There’s frankly not much to debate about the potential health hazards of tobacco, and more stringent smoking regulations are increasingly snuffing out the last vestiges of social acceptability. Not surprisingly, BAT’s share price, which traded at more than R900 in May 2017, is now back at levels seen in early 2014...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.